1. Revised recommendations for reducing the risk of human immunodeficiency virus transmission by blood and blood products Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, August 2020 Subject(s): Blood DonorsBlood TransfusionHIVHIV Infections -- prevention & controlUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Cancer clinical trial eligibility criteria: patients with HIV, hepatitis B Virus, or hepatitis C Virus Infections Publication: [Silver Spring, MD] : United States Food and Drug Administration, Oncology Center of Excellence, July 2020 Subject(s): Clinical Trials as TopicHepatitis BHepatitis CHIVNeoplasmsUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
